Zurich Cantonal Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-15,690
Closed -$49K – 2674
2020
Q3
$49K Hold
15,690
– – ﹤0.01% 2265
2020
Q2
$46K Hold
15,690
– – ﹤0.01% 2237
2020
Q1
$44K Buy
15,690
+6,528
+71% +$21K ﹤0.01% 2003
2019
Q4
$30K Hold
9,162
– – ﹤0.01% 2391
2019
Q3
$20K Hold
9,162
– – ﹤0.01% 2463
2019
Q2
$29K Hold
9,162
– – ﹤0.01% 2343
2019
Q1
$34K Hold
9,162
– – ﹤0.01% 2220
2018
Q4
$27K Hold
9,162
– – ﹤0.01% 2355
2018
Q3
$24K Hold
9,162
– – ﹤0.01% 2450
2018
Q2
$21K Hold
9,162
– – ﹤0.01% 2428
2018
Q1
$27K Hold
9,162
– – ﹤0.01% 2338
2017
Q4
$25K Hold
9,162
– – ﹤0.01% 2347
2017
Q3
$31K Buy
9,162
+4,640
+103% +$12.9K ﹤0.01% 2101
2017
Q2
$11K Sell
4,522
-41,426
-90% -$95.3K ﹤0.01% 2418
2017
Q1
$104K Buy
45,948
+14,000
+44% +$31K ﹤0.01% 1334
2016
Q4
$68K Sell
31,948
-700
-2% -$1.95K ﹤0.01% 1535
2016
Q3
$109K Buy
32,648
+16,821
+106% +$53.4K ﹤0.01% 1216
2016
Q2
$50K Buy
15,827
+11,305
+250% +$37.7K ﹤0.01% 1498
2016
Q1
$15K Hold
4,522
– – ﹤0.01% 2233
2015
Q4
$16K Buy
4,522
+2,763
+157% +$11.6K ﹤0.01% 2235
2015
Q3
$9K Buy
1,759
+1,055
+150% +$6.04K ﹤0.01% 2182
2015
Q2
$5K Hold
704
– – ﹤0.01% 2020
2015
Q1
$5K Buy
+704
New +$5.1K ﹤0.01% 2010
2013
Q4
– Sell
-27,778
Closed -$221K – 1022
2013
Q3
$221K Buy
+27,778
New +$223K 0.01% 806

Other funds holding PDLI

Zurich Cantonal Bank's PDLI Position: Q4 2020 in Review

Zurich Cantonal Bank sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 15,690 shares — an estimated $49K sold.

Zurich Cantonal Bank first reported a position in PDLI in Q3 2013 and held it in 24 quarters. The position peaked at $221K in Q3 2013. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Zurich Cantonal Bank reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Zurich Cantonal Bank sold 15,690 PDL BioPharma, Inc. shares in Q4 2020, an estimated $49K.
  • Zurich Cantonal Bank first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 24 quarters.
  • Zurich Cantonal Bank's PDL BioPharma, Inc. position peaked at $221K in Q3 2013.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Zurich Cantonal Bank's 13F filing for Q4 2020, filed 28 Jan 2021.